New drug approved for COPD

FDA approves drug for COPD patients The U.S. Food and Drug Administration has approved the once-daily bronchodilator inhalation spray olodaterol (Striverdi Respimat) for long-term treatment for patients with chronic obstructive pulmonary disease, including bronchitis...